• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核糖体展示技术:在疾病诊断与防控中的应用

Ribosome Display Technology: Applications in Disease Diagnosis and Control.

作者信息

Kunamneni Adinarayana, Ogaugwu Christian, Bradfute Steven, Durvasula Ravi

机构信息

Department of Medicine, Loyola University Medical Center, Chicago, IL 60153, USA.

Department of Animal and Environmental Biology, Federal University Oye-Ekiti, Ekiti State 371010, Nigeria.

出版信息

Antibodies (Basel). 2020 Jun 27;9(3):28. doi: 10.3390/antib9030028.

DOI:10.3390/antib9030028
PMID:32605027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7551589/
Abstract

Antibody ribosome display remains one of the most successful in vitro selection technologies for antibodies fifteen years after it was developed. The unique possibility of direct generation of whole proteins, particularly single-chain antibody fragments (scFvs), has facilitated the establishment of this technology as one of the foremost antibody production methods. Ribosome display has become a vital tool for efficient and low-cost production of antibodies for diagnostics due to its advantageous ability to screen large libraries and generate binders of high affinity. The remarkable flexibility of this method enables its applicability to various platforms. This review focuses on the applications of ribosome display technology in biomedical and agricultural fields in the generation of recombinant scFvs for disease diagnostics and control.

摘要

抗体核糖体展示技术自开发十五年以来,仍然是最成功的抗体体外筛选技术之一。直接生成完整蛋白质,特别是单链抗体片段(scFv)的独特可能性,促使该技术成为最重要的抗体生产方法之一。核糖体展示因其具有筛选大型文库和产生高亲和力结合物的优势能力,已成为用于诊断的高效低成本抗体生产的重要工具。该方法具有显著的灵活性,使其适用于各种平台。本综述重点关注核糖体展示技术在生物医学和农业领域的应用,即在疾病诊断和控制中生成重组单链抗体片段。

相似文献

1
Ribosome Display Technology: Applications in Disease Diagnosis and Control.核糖体展示技术:在疾病诊断与防控中的应用
Antibodies (Basel). 2020 Jun 27;9(3):28. doi: 10.3390/antib9030028.
2
Phage display antibodies for diagnostic applications.用于诊断应用的噬菌体展示抗体。
Biologicals. 2013 Jul;41(4):209-16. doi: 10.1016/j.biologicals.2013.04.001. Epub 2013 May 3.
3
Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties.核糖体展示:一种用于筛选和进化具有所需特性的特异性结合分子的强大展示技术。
Mol Biotechnol. 2019 Jan;61(1):60-71. doi: 10.1007/s12033-018-0133-0.
4
Selection of bisphenol A - single-chain antibodies from a non-immunized mouse library by ribosome display.通过核糖体展示从非免疫小鼠文库中筛选双酚A单链抗体。
Anal Biochem. 2015 Nov 1;488:59-64. doi: 10.1016/j.ab.2013.10.037. Epub 2013 Nov 19.
5
Ribosome display: a technology for selecting and evolving proteins from large libraries.核糖体展示:一种从大型文库中筛选和进化蛋白质的技术。
Methods Mol Biol. 2011;687:283-306. doi: 10.1007/978-1-60761-944-4_21.
6
Affinity maturation of phage display antibody populations using ribosome display.利用核糖体展示对噬菌体展示抗体库进行亲和力成熟。
Methods Mol Biol. 2012;805:163-90. doi: 10.1007/978-1-61779-379-0_10.
7
Applications of ribosome display to antibody drug discovery.核糖体展示技术在抗体药物发现中的应用。
Expert Opin Biol Ther. 2005 Jan;5(1):125-35. doi: 10.1517/14712598.5.1.125.
8
Next-Generation Sequencing of Antibody Display Repertoires.抗体展示文库的下一代测序。
Front Immunol. 2018 Feb 2;9:118. doi: 10.3389/fimmu.2018.00118. eCollection 2018.
9
Rapid Selection of High-Affinity Antibody scFv Fragments Using Ribosome Display.利用核糖体展示技术快速筛选高亲和力抗体单链抗体片段
Methods Mol Biol. 2018;1827:235-268. doi: 10.1007/978-1-4939-8648-4_13.
10
Development of Recombinant Antibody by Yeast Surface Display Technology.利用酵母表面展示技术开发重组抗体。
Curr Res Pharmacol Drug Discov. 2024 Jan 20;6:100174. doi: 10.1016/j.crphar.2024.100174. eCollection 2024.

引用本文的文献

1
High-throughput strategies for monoclonal antibody screening: advances and challenges.单克隆抗体筛选的高通量策略:进展与挑战
J Biol Eng. 2025 May 8;19(1):41. doi: 10.1186/s13036-025-00513-z.
2
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.基于肽的药物研发进展:递送平台、治疗药物与疫苗
Signal Transduct Target Ther. 2025 Mar 5;10(1):74. doi: 10.1038/s41392-024-02107-5.
3
Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.

本文引用的文献

1
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.针对 SARS-CoV-2 和其他人类冠状病毒的中和抗体。
Trends Immunol. 2020 May;41(5):355-359. doi: 10.1016/j.it.2020.03.007. Epub 2020 Apr 2.
2
Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display.利用无细胞核糖体展示技术生成和筛选泛丝状病毒单链抗体
Am J Trop Med Hyg. 2019 Jul;101(1):198-206. doi: 10.4269/ajtmh.18-0658.
3
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
揭开纳米抗体工程的新篇章:传统构建方法与人工智能驱动优化的进展
J Nanobiotechnology. 2025 Feb 6;23(1):87. doi: 10.1186/s12951-025-03169-5.
4
Peptide Aptamer-Paclitaxel Conjugates for Tumor Targeted Therapy.用于肿瘤靶向治疗的肽适配体-紫杉醇缀合物
Pharmaceutics. 2024 Dec 30;17(1):40. doi: 10.3390/pharmaceutics17010040.
5
Monoclonal antibodies: From magic bullet to precision weapon.单克隆抗体:从“魔弹”到“精准武器”。
Mol Biomed. 2024 Oct 11;5(1):47. doi: 10.1186/s43556-024-00210-1.
6
The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics.单链可变片段抗体的潜力:在未来治疗性和诊断性生物制剂中的作用。
J Immunol Res. 2024 Aug 9;2024:1804038. doi: 10.1155/2024/1804038. eCollection 2024.
7
A mini review on recent progress of microfluidic systems for antibody development.微流控系统在抗体开发方面的最新进展综述
J Diabetes Metab Disord. 2024 Jan 18;23(1):323-331. doi: 10.1007/s40200-024-01386-7. eCollection 2024 Jun.
8
Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies.单克隆抗体和下一代抗体的最新进展。
Immunohorizons. 2023 Dec 1;7(12):886-897. doi: 10.4049/immunohorizons.2300102.
9
Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics.小抗体,大应用:基于纳米抗体的癌症诊断与治疗
Cancers (Basel). 2023 Nov 29;15(23):5639. doi: 10.3390/cancers15235639.
10
Antiviral Drugs and Vaccines for Omicron Variant: A Focused Review.针对奥密克戎变异株的抗病毒药物和疫苗:聚焦综述
Can J Infect Dis Med Microbiol. 2023 Sep 8;2023:6695533. doi: 10.1155/2023/6695533. eCollection 2023.
基于受体结合域的中东呼吸综合征冠状病毒疫苗和治疗方法的进展。
Viruses. 2019 Jan 14;11(1):60. doi: 10.3390/v11010060.
4
Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies.核糖体展示技术快速生成高亲和力寨卡病毒中和单链抗体。
PLoS One. 2018 Nov 16;13(11):e0205743. doi: 10.1371/journal.pone.0205743. eCollection 2018.
5
Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties.核糖体展示:一种用于筛选和进化具有所需特性的特异性结合分子的强大展示技术。
Mol Biotechnol. 2019 Jan;61(1):60-71. doi: 10.1007/s12033-018-0133-0.
6
Ribosome display and selection of single-chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo.核糖体展示和单链可变片段筛选有效地抑制了微球在体外和体内的生长和进展。
Cancer Sci. 2018 May;109(5):1503-1512. doi: 10.1111/cas.13574. Epub 2018 Apr 24.
7
Selection of single-chain variable fragments specific for ESAT-6 antigen using ribosome display.利用核糖体展示技术筛选针对ESAT-6抗原的单链可变片段
Iran J Basic Med Sci. 2017 Mar;20(3):327-333. doi: 10.22038/ijbms.2017.8363.
8
Zika Virus: Medical Countermeasure Development Challenges.寨卡病毒:医学应对措施的研发挑战
PLoS Negl Trop Dis. 2016 Mar 2;10(3):e0004530. doi: 10.1371/journal.pntd.0004530. eCollection 2016 Mar.
9
Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses.通过噬菌体和核糖体展示分离高亲和力、中和性抗独特型抗体,用于免疫原性和药代动力学分析。
J Immunol Methods. 2015 Jan;416:49-58. doi: 10.1016/j.jim.2014.10.013. Epub 2014 Nov 7.
10
The Xylella fastidiosa PD1063 protein is secreted in association with outer membrane vesicles.桑萎蔫病菌PD1063蛋白与外膜囊泡相关联分泌。
PLoS One. 2014 Nov 26;9(11):e113504. doi: 10.1371/journal.pone.0113504. eCollection 2014.